Immune Thrombocytopenic Purpura Associated With Pfizer-BioNTech COVID-19 Vaccine Refractory to Conventional Treatment
Published In/Presented At
Ghous, G., Allahyar, Zafar, M.U., Tarar, Z.I., & Hafiz, M.H. (2021). Immune thrombocytopenic purpura associated with Pfizer-BioNTech COVID-19 vaccine refractory to conventional treatment. American Journal of Therapeutics, 28(4), pp. e521-e522.
Medicine and Health Sciences
Department of Medicine